RIBOLIA
LIVE

Serial Number

98928116

Owner

Suzhou Ribo Life Science Co., Ltd.

Attorney

Zhi Dong

Filing Date

Dec 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

RIBOLIA Trademark

Serial Number: 98928116

RIBOLIA is a trademark filed by Suzhou Ribo Life Science Co., Ltd. on December 30, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Suzhou Ribo Life Science Co., Ltd. (12 trademarks)

168 Yuanfeng Road,

Entity Type: 16

Trademark Details

Filing Date

December 30, 2024

Registration Date

Not Registered

Published for Opposition

July 15, 2025

Goods & Services

medicines for humans for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; crude drugs being pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemico-pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; biological preparations for medical purposes for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemical preparations for pharmaceutical purposes for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemical preparations for medical purposes for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; diagnostic preparations for medical purposes; potassium salts for medical purposes; sodium salts for medical purposes; pharmaceuticals for the treatment of cancer; anti-cancer preparations; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer; tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; anticoagulants; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; dietetic foods and beverages adapted for medical use; depuratives for the body; veterinary preparations for the treatment and diagnosis of gastrointestinal diseases, cardiovascular diseases, metabolic diseases, and liver diseases; pesticides; dressings, medical; composite materials for dental purposes; diapers for pets

technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development services; research in the field of pharmaceuticals; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; medical research; testing of pharmaceuticals; industrial design

Filing History

CASE RETURNED TO EXAMINATION
Jul 10, 2026 OTHE
ASSIGNED TO PETITION STAFF
Jul 9, 2026 APET
TEAS PETITION TO AMEND BASIS RECEIVED
May 20, 2026 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 10, 2026 EXRA
SOU EXTENSION 1 GRANTED
Mar 9, 2026 EX1G
SOU EXTENSION 1 FILED
Mar 9, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 9, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 9, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2025 CNSA
ASSIGNED TO EXAMINER
Jun 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2025 NWOS
NEW APPLICATION ENTERED
Dec 30, 2024 NWAP